| BYLD | FBND | BYLD / FBND | |
| Gain YTD | 0.551 | -0.170 | -324% |
| Net Assets | 447M | 27B | 2% |
| Total Expense Ratio | 0.13 | 0.36 | 36% |
| Turnover | 96.00 | 246.00 | 39% |
| Yield | 5.34 | 4.69 | 114% |
| Fund Existence | 12 years | 12 years | - |
| BYLD | FBND | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 45% | N/A |
| Stochastic ODDS (%) | 1 day ago 45% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 33% | 1 day ago 47% |
| MACD ODDS (%) | 1 day ago 37% | 1 day ago 47% |
| TrendWeek ODDS (%) | 1 day ago 44% | 1 day ago 54% |
| TrendMonth ODDS (%) | 1 day ago 42% | 1 day ago 53% |
| Advances ODDS (%) | 10 days ago 41% | 10 days ago 53% |
| Declines ODDS (%) | 2 days ago 40% | 2 days ago 50% |
| BollingerBands ODDS (%) | 1 day ago 53% | 1 day ago 50% |
| Aroon ODDS (%) | 1 day ago 49% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JPUS | 142.13 | 0.92 | +0.65% |
| JPMorgan Diversified Return US Eq ETF | |||
| EMLP | 44.84 | N/A | N/A |
| First Trust North Amer Engy InfrasETF | |||
| BIB | 102.92 | N/A | N/A |
| ProShares Ultra Nasdaq Biotechnology | |||
| SCOW | 22.05 | N/A | N/A |
| Pacer S&P SmCp 600 Qul FCF Aristcrts ETF | |||
| QTAC | 22.67 | -0.41 | -1.77% |
| Q3 All-Season Tactical Advantage ETF | |||
A.I.dvisor tells us that FBND and CZR have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBND and CZR's prices will move in lockstep.
| Ticker / NAME | Correlation To FBND | 1D Price Change % | ||
|---|---|---|---|---|
| FBND | 100% | +0.09% | ||
| CZR - FBND | 17% Poorly correlated | +0.13% | ||
| NFE - FBND | 0% Poorly correlated | +5.34% | ||
| CRC - FBND | -1% Poorly correlated | -1.44% | ||
| EQT - FBND | -8% Poorly correlated | -0.67% |